CHK2 is a serine threonine kinase that is mutated in certain families with a high risk of breast cancer and exhibits a Li‐Fraumeni syndrome phenotype, while having normal TP53, BRCA‐1, and BRCA‐2 sequences.52 This evidence concerns the gene BRCA1 and breast cancer.